Patents by Inventor Helen Armstrong

Helen Armstrong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted sulfonamides
    Publication number: 20070105914
    Abstract: The substituted sulfonamides of the invention are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.
    Type: Application
    Filed: September 14, 2004
    Publication date: May 10, 2007
    Inventors: Helen Armstrong, Linda Chang, Ravindra Guthikonda, William Hagmann, Linus Lin, Shrenik Shah
  • Substituted amides
    Publication number: 20050234061
    Abstract: Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds of the present invention are useful as centrally acting drugs in the treatment of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome and the inflammatory sequelae of viral encephalitis, cerebral vascular accidents, and head trauma, anxiety disorders, stress, epilepsy, Parkinson's disease, movement disorders, and schizophrenia. The compounds are also useful for the treatment of substance abuse disorders, the treatment of obesity or eating disorders, as well as the treatment of asthma, constipation, chronic intestinal pseudo-obstruction, and cirrhosis of the liver.
    Type: Application
    Filed: April 19, 2005
    Publication date: October 20, 2005
    Inventors: William Hagmann, Linus Lin, Shrenik Shah, Ravindra Guthikonda, Hongbo Qi, Linda Chang, Ping Liu, Helen Armstrong, James Jewell, Thomas Lanza
  • Aqueous detergent concentrates for rough, especially profiled tiles and flags
    Patent number: 6544350
    Abstract: Aqueous detergent concentrates for rough, especially profiled tiles and flags, based on nonionic, anionic, amphoteric surfactants, with or without the use of customary auxiliaries and additives, said concentrates comprising quaternary alkoxylated amine compounds as cleaning enhancers.
    Type: Grant
    Filed: July 19, 2001
    Date of Patent: April 8, 2003
    Assignee: Goldschmidt, AG
    Inventors: Felix Muller, Jorg Peggau, Helen Armstrong
  • Aqueous detergent concentrates for rough, especially profiled tiles and flags
    Publication number: 20020169093
    Abstract: Aqueous detergent concentrates for rough, especially profiled tiles and flags, based on nonionic, anionic, amphoteric surfactants, with or without the use of customary auxiliaries and additives, said concentrates comprising quaternary alkoxylated amine compounds as cleaning enhancers.
    Type: Application
    Filed: July 19, 2001
    Publication date: November 14, 2002
    Applicant: Goldschmidt AG
    Inventors: Felix Muller, Jorg Peggau, Helen Armstrong